Nasogastric tube-administered alectinib achieved long-term survival in a crizotinib-refractory nonsmall cell lung cancer patient with a poor performance status
about
Nasogastric tube-administered alectinib achieved long-term survival in a crizotinib-refractory nonsmall cell lung cancer patient with a poor performance status
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Nasogastric tube-administered ...... with a poor performance status
@ast
Nasogastric tube-administered ...... with a poor performance status
@en
type
label
Nasogastric tube-administered ...... with a poor performance status
@ast
Nasogastric tube-administered ...... with a poor performance status
@en
prefLabel
Nasogastric tube-administered ...... with a poor performance status
@ast
Nasogastric tube-administered ...... with a poor performance status
@en
P2093
P2860
P356
P1476
Nasogastric tube-administered ...... with a poor performance status
@en
P2093
Kohei Fujita
Koichi Nakatani
Tadashi Mio
Young Hak Kim
P2860
P304
P356
10.1002/CCR3.973
P50
P577
2017-04-26T00:00:00Z